Identifying specific biomarkers and clinical characteristics is crucial for predicting a patient's response to both existing and emerging treatments for chronic spontaneous urticaria, thereby moving ...

Food allergy management is shifting from passive strategies — such as avoidance, carrying epinephrine and hope — to proactive ...

The agreement is for Kashiv BioSciences’ biosimilar candidate to Genentech and Novartis AG’s Xolair (omalizumab) in the ...

A new study published in the Journal of American Medical Association found that Rilzabrutinib decreased itching and hives ...

A new international study led by researchers at McMaster University has identified the most effective and safest treatments ...

Scientists at Northwestern University have discovered a drug that could offer a new approach to treating life-threatening ...

In managing antihistamine-refractory chronic urticaria, omalizumab and remibrutinib stand out among the most effective treatments across multiple patient-important outcomes, followed by dupilumab ...

A Northwestern study found that the asthma drug zileuton prevents food allergy anaphylaxis in mice by blocking allergen absorption in the gut. The research reveals a new mechanism driving allergic ...

A drug already FDA-approved for asthma was found to nearly eliminate life-threatening allergic reactions to food allergens in ...

Kashiv BioSciences, LLC and MS Pharma today announced that the companies have entered into a license and supply agreement for ...

Among adults with severe asthma, those with healthy weight, overweight, obesity and severe obesity each had improvements in ...

A drug used for asthma has been found to treat food allergies "shockingly well", in a breakthrough that could offer new protection for millions affected. This is the discovery of Northwestern Medicine ...